Ballard Power Systems Inc. (BLDP)
After the closing bell on Friday, BLDP said that it signed a new long-term license and supply agreement with an existing partner in China, Guangdong Synergy Hydrogen Power Technology Co., Ltd., to provide fuel cell Power Products and Technology Solutions in support of the planned deployment of approximately 300 fuel cell-powered buses in the cities of Foshan and Yunfu, China.
According to BLDP, the deal has an estimated initial value of $17 million through 2016, with the opportunity for significant recurring royalties starting in 2017.
BLDP provides clean energy products that reduce customer costs and risks, and helps customers solve difficult technical and business challenges in their fuel cell programs.
More about Ballard Power Systems Inc. (BLDP) at www.ballard.com
OncoSec Medical Inc. (ONCS)
ONCS announced results from a Phase II trial demonstrating that its investigational therapy, ImmunoPulse(TM) IL-12, promotes tumor-specific, systemic anti-tumor immune responses in patients with Merkel cell carcinoma, a rare, aggressive cancer with a disease-associated mortality estimated to be three times that of malignant melanoma and affects approximately 1,600 people per year in the US.
According to the Principal Investigator of the trial, the findings support the hypothesis that intratumoral IL-12 DNA with electroporation promotes tumor immunogenicity and the results confirm the potential of this approach to make a clinically meaningful impact on patient outcomes for this virus-associated cancer.
ONCS said that the Phase II trial results are consistent with what the company has previously observed in metastatic melanoma and underscore the broad-reaching potential of ImmunoPulse IL-12 in driving immunogenicity.
ONCS is a biotechnology company developing DNA-based intratumoral immunotherapies with an investigational technology, ImmunoPulse(TM), for the treatment of cancer. ImmunoPulse is designed to enhance the local delivery and uptake of DNA-based immune-targeting agents, such as IL-12.
More about OncoSec Medical Inc. (ONCS) at www.oncosec.com.
Crown Equity Holdings Inc. (CRWE)
The company is currently developing its CRWE WORLD ( www.crweworld.com ), a community targeted platform which goal is to be a one-stop shop for the various needs of online consumers in a range of marketing specialties like Real Estate, Coupons & Deals, Business Directory and more
CRWE WORLD’s business model is based on selling advertising to businesses targeting their marketing message locally, nationally, internationally and also to target potential clients for an specific location, such as within a certain zip code.
CRWE’s Curbiz ( www.curbiz.com ), in development stage, is an online business directory connecting people with local, state, country and global businesses. Curbiz will provide local advertising services, including free and paid business listing services to businesses of various sizes, as well as enable businesses to deliver targeted search advertising to large local audiences through its Website and partnership with the CRWE WORLD Network.
CRWE provides marketing solutions that boost customer awareness and merchant visibility on the Internet.
More about Crown Equity Holdings Inc. (CRWE) at www.crownequityholdings.com
Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. CRWE PR Finance is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read Full Disclaimer at CRWE PR Finance www.finance.crwe-pr.com/disclaimer